Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -5.38% | 430.14 | 0.0% | $5769.95m | |
| BNTX | BioNTech SE | -5.53% | 333.48 | 0.0% | $994.80m | |
| NVAX | Novavax, Inc. | -3.55% | 248.16 | 79.4% | $950.95m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -0.46% | 8.65 | 0.7% | $604.67m | |
| AMGN | Amgen, Inc. | -0.67% | 213.61 | 1.4% | $550.92m | |
| GILD | Gilead Sciences, Inc. | -0.70% | 71.19 | 1.0% | $455.28m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.18% | 638.90 | 2.7% | $418.56m | |
| TECH | Bio-Techne Corp. | 0.37% | 538.88 | 4.5% | $356.85m | |
| ILMN | Illumina, Inc. | -0.09% | 432.82 | 3.5% | $356.73m | |
| BIIB | Biogen, Inc. | -0.51% | 291.71 | 1.7% | $309.48m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.80% | 183.61 | 1.9% | $245.25m | |
| ISEE | IVERIC bio, Inc. | 0.86% | 16.37 | 0.0% | $193.25m | |
| DVAX | Dynavax Technologies Corp. | 1.17% | 19.83 | 5.7% | $156.65m | |
| LIFE | aTyr Pharma, Inc. | -17.87% | 10.25 | 2.1% | $156.36m | |
| BGNE | BeiGene Ltd. | -1.53% | 379.52 | 1.3% | $144.32m |
Company Profile
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.